Better than Ozempic? Novel GLP-1 drug shows promise in mouse model
A new study from the Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen used GLP-1 drugs as a "Trojan horse" to increase neuroplasticity in the brain, which doubled weight loss in mice.